Patient Name : Mr.
LAVI Specimen Drawn ON : 13/May/2025 10:00AM
Age/Gender : 25 YRS /M Specimen Received ON : 14/May/2025 08:33AM
UHID/MR No : ADEL.0002467220 Report Date : 14/May/2025 09:45AM
Barcode No : C3343895 Client Code : UP209
Ref Doctor : Dr.MEERUT LAB Visit ID : MDEL2468874
Ref Customer : SELF Client Name : RAJ PATHOLOGY
DEPARTMENT OF HAEMATOLOGY
HEALTH CHECK PROFILE (30P)
Test Name Result Unit Bio. Ref. Range Method
COMPLETE BLOOD COUNT(CBC)23
R.B.C 4.73 Millions/cumm 4.5-5.5 Impedance variation
Haemoglobin 15.0 g/dl 13-17 Spectrophotometry
Packed Cell Volume 41.90 % 40.0-50.0 Analogical Integration
MCV 88.58 fL 80-100
MCH 31.71 pg 27.0-32.0 Calculated
MCHC 35.8 g/dL 27.0-48.0 Calculated
RDW-CV 13.1 % 11.5-14.0 Calculated
Platelet Count 160 x1000/uL 150-450 Impedance Variation
Total WBC Count 8070 /cumm 4000-10000 Impedance Variation
TNC 9.80
MPV 9.00 % 9.1-11.9 Calculated
PCT 0.16 % 0.18-0.39 Calculated
PDW 16.80 % 9.0-15.0 Calculated
Differential Leucocyte Count
Neutrophil 63 % 40.0-80.0 flow cytometry/manual
Lymphocyte 30 % 20.0-40.0 flow cytometry/manual
Monocytes 05 % 2-10 flow cytometry/manual
Eosinophils 02 % 01-06 Flow cytometry/manual
Basophils 00 % 0-2 Flow cytometry/manual
Absolute Neutrophils 5.08 1000/µL 2.00-7.00
Absolute Lymphocytes 2.42 1000/µL 1.00-3.00
Absolute Monocytes 0.40 1000/µL 0.20-1.00
Absolute Eosinophils 0.16 1000/µL 0.02-0.50
Neutrophil-Lymphocyte Ratio 2.10 Calculated
Lymphocyte-Monocyte Ratio 6 Calculated
Platelet-Lymphocyte Ratio 5 Calculated
QR CODE Page 1 of 7
Patient Name : Mr. LAVI Specimen Drawn ON : 13/May/2025 10:00AM
Age/Gender : 25 YRS /M Specimen Received ON : 14/May/2025 08:33AM
UHID/MR No : ADEL.0002467220 Report Date : 14/May/2025 10:18AM
Barcode No : C3343895 Client Code : UP209
Ref Doctor : Dr.MEERUT LAB Visit ID : MDEL2468874
Ref Customer : SELF Client Name : RAJ PATHOLOGY
DEPARTMENT OF HAEMATOLOGY
HEALTH CHECK PROFILE (30P)
Test Name Result Unit Bio. Ref. Range Method
Erythrocyte Sedimentation Rate (ESR) 15 mm/h 0-20 Westergren
QR CODE Page 2 of 7
Patient Name : Mr. LAVI Specimen Drawn ON : 13/May/2025 10:00AM
Age/Gender : 25 YRS /M Specimen Received ON : 14/May/2025 07:52AM
UHID/MR No : ADEL.0002467220 Report Date : 14/May/2025 09:26AM
Barcode No : C3343896 Client Code : UP209
Ref Doctor : Dr.MEERUT LAB Visit ID : MDEL2468874
Ref Customer : SELF Client Name : RAJ PATHOLOGY
DEPARTMENT OF BIOCHEMISTRY
HEALTH CHECK PROFILE (30P)
Test Name Result Unit Bio. Ref. Range Method
GLUCOSE FASTING
Sample Type : Sod.Fluoride - F
Glucose Fasting 77.9 mg/dl 70.0 - 110.0 GOD-POD
Interpretation (In accordance with the American diabetes association guidelines):
ꞏ A fasting plasma glucose level below 110 mg/dL is considered normal.
ꞏ A fasting plasma glucose level between 100-126 mg/dL is considered as glucose intolerant or pre diabetic. A fasting and
post-prandial blood sugar test (after consumption of 75 gm of glucose) is recommended for all such patients.
ꞏ A fasting plasma glucose level of above 126 mg/dL is highly suggestive of a diabetic state. A repeat fasting test is
strongly recommended for all such patients. A fasting plasma glucose level in excess of 126 mg/dL on both the occasions is
confirmatory of a diabetic state.
EGFR (ESTIMATED GLOMERULAR FILTRATION RATE)
Creatinine 1.25 mg/dL 0.70-1.40 Jaffe Kinetic
Blood Urea Nitrogen (BUN) 15.30 mg/dl 6.00-20.0 Spectro-photometry
Albumin (Serum) 4.41 g/dL 3.5-5.5 Bromo Cresol Green
(BCG)
EGFR By MDRD 74.92 mL/min/1.73 Spectrophotometric -
m2 Calculated
COMMENT-The Kidney Disease Improving Global Outcomes (KDIGO) guideline defines CKD by the presence of glomerular
filtration rate (GFR) <60 mL/min/1.73m2 for >3 months and/or evidence of kidney damage (eg, structural abnormalities, histologic
abnormalities, albuminuria, urinary sediment abnormalities, renal tubular disorders, and/or history of kidney transplantation) for
>3months.2 Thus, monitoring should include tests for GFR, albuminuria, and urine sediment.
CLINICAL USE-
• Detect chronic kidney disease (CKD) in adults.
• Monitor CKD therapy and/or progression in adults.
Interpretation of eGFR Values
eGFR (mL/min/1.73m2 ) Interpretation
90 Normal
60-89 Mild decrease
45-59 Mild to moderate decrease
30-44 Moderate to severe decrease
15-29 Severe decrease
<15 Kidney failure
QR CODE Page 3 of 7
Patient Name : Mr. LAVI Specimen Drawn ON : 13/May/2025 10:00AM
Age/Gender : 25 YRS /M Specimen Received ON : 14/May/2025 07:52AM
UHID/MR No : ADEL.0002467220 Report Date : 14/May/2025 09:26AM
Barcode No : C3343896 Client Code : UP209
Ref Doctor : Dr.MEERUT LAB Visit ID : MDEL2468874
Ref Customer : SELF Client Name : RAJ PATHOLOGY
DEPARTMENT OF BIOCHEMISTRY
HEALTH CHECK PROFILE (30P)
Test Name Result Unit Bio. Ref. Range Method
LIVER FUNCTION TEST (LFT)-EXTENDED
Sample Type : SERUM
Bilirubin Total 0.29 mg/dl <1.1 Diazotized Sulfanilic
Bilirubin Direct 0.13 mg/dl 0-0.3 Diazotized Sulfanilic
Bilirubin Indirect 0.16 mg/dl 0.30-1.00 Calculated
SGOT (AST) 48.7 U/L <31.0 IFCC without pyridoxal
phosphate
SGPT (ALT) 41.0 U/L <33.0 IFCC without pyridoxal
phosphate
Alkaline Phosphatase (ALP) 96.3 U/L 40-129 Spectrophotometry
Gamma Glutamyl Transferase (GGT) 27.4 U/L 15-60 L-Gamma-glutamyl-3-
carboxy-4-nitroanilide
Substrate
Protein Total 7.5 g/dL 6.6-8.7 Biuret
Albumin (Serum) 4.41 g/dL 3.5-5.5 Bromo Cresol Green
(BCG)
Globulin 3.09 g/dL 2.50-3.50 Calculated
A/G Ratio 1.43 1.5-2.5 Calculated
Interpretation:- Liver blood tests, or liver function tests, are used to detect and diagnose disease or inflammation of the liver.
Elevated aminotransferase (ALT, AST) levels are measured as well as alkaline phosphatase, albumin, and bilirubin. Some
diseases that cause abnormal levels of ALT and AST include hepatitis A, B, and C, cirrhosis, iron overload, and Tylenol liver
damage. Medications also cause elevated liver enzymes. There are less common conditions and diseases that also cause elevated
liver enzyme levels.: Liver blood tests, or liver function tests, are used to detect and diagnose disease or inflammation of the liver.
Elevated aminotransferase (ALT, AST) levels are measured as well as alkaline phosphatase, albumin, and bilirubin. Some
diseases that cause abnormal levels of ALT and AST include hepatitis A, B, and C, cirrhosis, iron overload, and Tylenol liver
damage. Medications also cause elevated liver enzymes.There are less common conditions and diseases that also cause elevated
liver enzyme levels.
QR CODE Page 4 of 7
Patient Name : Mr. LAVI Specimen Drawn ON : 13/May/2025 10:00AM
Age/Gender : 25 YRS /M Specimen Received ON : 14/May/2025 07:52AM
UHID/MR No : ADEL.0002467220 Report Date : 14/May/2025 09:26AM
Barcode No : C3343896 Client Code : UP209
Ref Doctor : Dr.MEERUT LAB Visit ID : MDEL2468874
Ref Customer : SELF Client Name : RAJ PATHOLOGY
DEPARTMENT OF BIOCHEMISTRY
HEALTH CHECK PROFILE (30P)
Test Name Result Unit Bio. Ref. Range Method
LIPID PROFILE BASIC
Sample Type : SERUM
Total Cholesterol 179.7 mg/dL Desirable - 200, Borderline high - CHO-POD
200-239, High ‐ ≥ 240
Triglyceride 165.7 mg/dL 0.0-150 :Normal GPO-POD
151-199:Border Line >=200 :High
200.0-499.0 High
~> 500 Very High
HDL Cholesterol 47.4 mg/dL 40-60 Direct (PVS/PEGME
precipitation & Trinder
reaction)
Non HDL Cholesterol 132.30 mg/dL < 130 mg/dL Calculated
VLDL Cholesterol 33.1 mg/dL 2.00-30.00 Calculated
LDL Cholesterol 99.16 mg/dL 0-130 :Normal~131- Direct (PVS/PEGME
155:Borderline~>=160 :High precipitation & Trinder
reaction)
Cholesterol/HDL Ratio 3.79 Ratio <4.00 Calculated
LDL / HDL Cholestrol Ratio 2.09 Ratio <3.50 Calculated
HDL/LDL Cholesterol Ratio 0.48 Ratio <3.50 Calculated
Cholesterol Level mg/dL
Desirable 200
Borderline High 200 - 239
High ≥ 240
Risk Modifiers As per ASCVD
PARAMETRS mg/dL
HDL <40 - low
>60 - high
LDL <100 optimal
TRIGLYCERIDE LEVELS < 150 for fasting
< 175 for Non fasting
Treatments Goal as per LAI 2023
TREATMENT GOAL
ASCVD RISK CATEGORY LDL-C in mg/dL Primary Target NonHDL-C in mg/dL CO-Primary Target
LOW <100 <130
MODERATE <100 <130
HIGH <70 <100
VERY HIGH <50 <80
EXTREME (A) <50 or <30 <80 or <60
EXTREME (B) <30 <60
QR CODE Page 5 of 7
Patient Name : Mr. LAVI Specimen Drawn ON : 13/May/2025 10:00AM
Age/Gender : 25 YRS /M Specimen Received ON : 14/May/2025 07:52AM
UHID/MR No : ADEL.0002467220 Report Date : 14/May/2025 09:26AM
Barcode No : C3343896 Client Code : UP209
Ref Doctor : Dr.MEERUT LAB Visit ID : MDEL2468874
Ref Customer : SELF Client Name : RAJ PATHOLOGY
DEPARTMENT OF BIOCHEMISTRY
HEALTH CHECK PROFILE (30P)
Test Name Result Unit Bio. Ref. Range Method
Kidney Function Test EXTENDED
Urea 32.74 mg/dl 18.0-45.0 Spectro-photometry
Creatinine 1.25 mg/dL 0.70-1.40 Jaffe Kinetic
Calcium 9.5 mg/dL 8.6-10.2 NM-BAPTA
Uric Acid 3.87 mg/dl 4.40-7.60 Spectro-photometry
Phosphorus 4.15 mg/dL 2.50-5.00 Ammonium molybdate
UV
Sodium (NA+) 142.30 mmol/L 135.0-145.0 Ion Selective Electrode
Potassium (K+) 4.09 mmol/L 3.50-5.50 Ion Selective Electrode
Chloride 100.60 mmol/L 98.0-109.0 Ion Selective Electrode
Blood Urea Nitrogen (BUN) 15.3 mg/dl 6.00-20.0 Spectro-photometry
Bun / Creatinine Ratio 12.24 Ratio 0.0-23.0 Calculated
Urea / Creatinine Ratio 26.19 Ratio 20-35 Calculated
Interpretation:- Kidney blood tests, or Kidney function tests, are used to detect and diagnose disease of the Kidney.
The higher the blood levels of urea and creatinine, the less well the kidneys are working.
The level of creatinine is usually used as a marker as to the severity of kidney failure. (Creatinine in itself is not harmful, but a high
level indicates that the kidneys are not working properly. So, many other waste products will not be cleared out of the
bloodstream.) You normally need treatment with dialysis if the level of creatinine goes higher than a certain value.
Dehydration can also be a come for increases in urea level.
Before and after starting treatment with certain medicines. Some medicines occasionally cause kidney damage (Nephrotoxic Drug)
as a side-effect. Therefore, kidney function is often checked before and after starting treatment with certain medicines.
QR CODE Page 6 of 7
Patient Name : Mr. LAVI Specimen Drawn ON : 13/May/2025 10:00AM
Age/Gender : 25 YRS /M Specimen Received ON : 14/May/2025 07:52AM
UHID/MR No : ADEL.0002467220 Report Date : 14/May/2025 09:14AM
Barcode No : C3343896 Client Code : UP209
Ref Doctor : Dr.MEERUT LAB Visit ID : MDEL2468874
Ref Customer : SELF Client Name : RAJ PATHOLOGY
DEPARTMENT OF IMMUNOASSAY
HEALTH CHECK PROFILE (30P)
Test Name Result Unit Bio. Ref. Range Method
THYROID PROFILE
Sample Type : SERUM
Triiodothyronine Total (T3) 0.68 ng/mL 0.70-2.04 Chemiluminescence
Immunoassay (CLIA)
Thyroxine Total (T4) 4.12 ug/dL 4.6-10.5 Chemiluminescence
Immunoassay (CLIA)
TSH (4th Generation) 5.234 uIU/mL 0.40-4.20 Chemiluminescence
Immunoassay (CLIA)
PREGNANCY REFERENCE RANGE for TSH IN uIU/mL (As per American Thyroid Association.)
1st Trimester 0.10-2.50 uIU/mL
2nd Trimester 0.20-3.00 uIU/mL
3rd Trimester 0.30-3.00 uIU/mL
INTERPRETATION-
1. Primary hyperthyroidism is accompanied by elevated serum T3 & T4 values along with depressed TSH level.
2 .Primary hypothyroidism is accompanied by depressed serum T3 and T4 values & elevated serum TSH levels.
3. Normal T4 levels accompanied by high T3 levels and low TSH are seen in patients with T3 thyrotoxicosis.
4. Normal or low T3 & high T4 levels indicate T4 thyrotoxicosis ( problem is conversion of T4 to T3)
5. Normal T3 & T4 along with low TSH indicate mild / subclinical HYPERTHYROIDISM .
6. Normal T3 & low T4 along with high TSH is seen in HYPOTHYROIDISM .
7. Normal T3 & T4 levels with high TSH indicate Mild / Subclinical HYPOTHYROIDISM .
8. Slightly elevated T3 levels may be found in pregnancy and in estrogen therapy while depressed levels may be
encountered in severe illness , malnutrition , renal failure and during therapy with drugs like propanolol.
9. Although elevated TSH levels are nearly always indicative of primary hypothroidism . rarely they can result from TSH
secreting pituitary tumours ( seconday hyperthyroidism )
*TSH IS DONE BY ULTRASENSITIVE 4th GENERATION CHEMIFLEX ASSAY*
COMMENTS:
Assay results should be interpreted in context to the clinical condition and associated results of other investigations.
Previous treatment with corticosteroid therapy may result in lower TSH levels while thyroid hormone levels are normal.
Results are invalidated if the client has undergone a radionuclide scan within 7-14 days before the test. Abnormal thyroid
test findings often found in critically ill clients should be repeated after the critical nature of the condition is resolved.The
production, circulation, and disintegration of thyroid hormones are altered throughout the stages of pregnancy.
NOTE-TSH levels are subject to circardian variation,reaching peak levels between 2-4AM and ninimum between 6-10 PM. The variation is the order of 50% hence time of the day has influence on the
measures serum TSH concentration.Dose and time of drug intake also influence the test result. Reference ranges are from Teitz fundamental of clinical chemistry 7th ed.
*** End Of Report ***
QR CODE Page 7 of 7
